Howe & Rusling’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-42
Closed -$1K 792
2022
Q3
$1K Sell
42
-31
-42% -$1.29K ﹤0.01% 988
2022
Q2
$3K Sell
73
-17
-19% -$780 ﹤0.01% 801
2022
Q1
$4K Buy
90
+1
+1% +$50 ﹤0.01% 727
2021
Q4
$5K Buy
+89
New +$3.96K ﹤0.01% 680
2014
Q4
Sell
-200
Closed -$9K 930
2014
Q3
$9K Sell
200
-97,850
-100% -$5.21M ﹤0.01% 508
2014
Q2
$7.25M Sell
98,050
-919
-0.9% -$72.4K 1.63% 14
2014
Q1
$8.2M Buy
98,969
+18,586
+23% +$1.63M 2.01% 12
2013
Q4
$11.1M Buy
80,383
+30,557
+61% +$3.6M 2.8% 4
2013
Q3
$4.92M Buy
+49,826
New +$4.23M 1.8% 15

Other funds holding NUS

Howe & Rusling's NUS Position: Q4 2022 in Review

Howe & Rusling sold out of Nu Skin (NUS) in Q4 2022, closing a stake of 42 shares — an estimated $1K sold.

Howe & Rusling first reported a position in NUS in Q3 2013 and held it in 9 quarters. The position peaked at $11.1M in Q4 2013. 218 funds tracked by Wall St. Rank hold NUS as of Q4 2022.

  • Howe & Rusling reported no remaining Nu Skin position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 42 Nu Skin shares in Q4 2022, an estimated $1K.
  • Howe & Rusling first reported a position in Nu Skin in Q3 2013 and held it in 9 quarters.
  • Howe & Rusling's Nu Skin position peaked at $11.1M in Q4 2013.
  • 218 funds tracked by Wall St. Rank held Nu Skin as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.